Joint Advisory Group on Gastrointestinal Endoscopy (JAG) framework for managing underperformance in gastrointestinal endoscopy.
endoscopy
Journal
Frontline gastroenterology
ISSN: 2041-4137
Titre abrégé: Frontline Gastroenterol
Pays: England
ID NLM: 101528589
Informations de publication
Date de publication:
2022
2022
Historique:
received:
26
02
2021
revised:
16
04
2021
accepted:
21
04
2021
entrez:
31
12
2021
pubmed:
1
1
2022
medline:
1
1
2022
Statut:
epublish
Résumé
Underperformance can be defined as performance which persistently falls below a desired minimum standard considered acceptable for patient care. Within gastrointestinal endoscopy, underperformance may be multifactorial, related to an individual's knowledge, skills, attitudes, health or external factors. If left unchecked, underperformance has the potential to impact on care and ultimately patient safety. Managing underperformance should be a key attribute of high-quality endoscopy service, as recognised in the Joint Advisory Group on Gastrointestinal Endoscopy (JAG) accreditation process. However, it is recognised that not all services have robust mechanisms to do this. This article provides the JAG position on managing underperformance in endoscopy, defined through a practical framework. This follows a stepwise process of detecting underperformance, verification, identification of additional causative factors, providing support and reassessment. Detection and verification of issues may require use of multiple evidence sources, including performance data, feedback and appraisal reports. Where technical underperformance is identified, this should be risk stratified by potential risk to patient safety. Support should be tailored to each individual case based on the type of underperformance detected, any causative factors with an action plan developed. Support may include coaching, mentoring, training and upskilling. Wider support from the medical director's office or external services may also be required. Monitoring and reassessment is a crucial part of the overall process.
Identifiants
pubmed: 34970427
doi: 10.1136/flgastro-2021-101830
pii: flgastro-2021-101830
pmc: PMC8666862
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
5-11Informations de copyright
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: CR has received grant funding from ARC medical, Norgine, Medtronic and Olympus medical. He was an expert witness for ARC medical.
Références
Endoscopy. 2020 Oct;52(10):879-883
pubmed: 32572861
Gut. 2016 Dec;65(12):1923-1929
pubmed: 27531829
Gut. 2017 Nov;66(11):1886-1899
pubmed: 28821598
Br J Anaesth. 2013 Apr;110(4):529-44
pubmed: 23454826
Gastrointest Endosc. 2018 Oct;88(4):737-744.e1
pubmed: 30220302
BMJ Qual Saf. 2019 Jan;28(1):74-84
pubmed: 30045864
Frontline Gastroenterol. 2019 Apr;10(2):148-153
pubmed: 31205655